Activin and Inhibin

cis-ccc_R08 (compound 1) is a flavonoid derivative that can be used in the study of hepatitis B virus ( HBV ) infection. cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor.Form:Solid.

cis-ccc_R08 (compound 1) is a flavonoid derivative that can be used in the study of hepatitis B virus ( HBV ) infection. cis-ccc_R08 is a cccDNA (covalently closed circular DNA) inhibitor.Form:Solid.

Citalopram-d 4 (hydrobromide) is the deuterium labeled Citalopram hydrobromide. Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI).

CJJ300 is a transforming growth factor-β ( TGF-β ) inhibitor with an IC 50 of 5.3 µM. CJJ300 inhibits TGF-β signaling by disrupting the formation of the TGF-β-TβR-I-TβR-II signaling complexIn VitroCJJ300 disturbs protein-protein interactions and

CJJ300 is a transforming growth factor-β ( TGF-β ) inhibitor with an IC 50 of 5.3 µM. CJJ300 inhibits TGF-β signaling by disrupting the formation of the TGF-β-TβR-I-TβR-II signaling complexIn VitroCJJ300 disturbs protein-protein interactions and

CJJ300 is a transforming growth factor-β ( TGF-β ) inhibitor with an IC 50 of 5.3 µM. CJJ300 inhibits TGF-β signaling by disrupting the formation of the TGF-β-TβR-I-TβR-II signaling complexIn VitroCJJ300 disturbs protein-protein interactions and

CJJ300 is a transforming growth factor-β ( TGF-β ) inhibitor with an IC 50 of 5.3 µM. CJJ300 inhibits TGF-β signaling by disrupting the formation of the TGF-β-TβR-I-TβR-II signaling complexIn VitroCJJ300 disturbs protein-protein interactions and

CJJ300 is a transforming growth factor-β ( TGF-β ) inhibitor with an IC 50 of 5.3 µM. CJJ300 inhibits TGF-β signaling by disrupting the formation of the TGF-β-TβR-I-TβR-II signaling complexIn VitroCJJ300 disturbs protein-protein interactions and

CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC 50 of 2.3 nMForm:SolidIC50&amp: Target:IC50: 2.3 nM (Cholesteryl ester

CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC 50 of 2.3 nMForm:SolidIC50&amp: Target:IC50: 2.3 nM (Cholesteryl ester

CKD-519 is a selective and potent cholesteryl ester transfer protein (CETP) inhibitor, which inhibits CETP-mediated transfer of cholesteryl ester in human serum with an IC 50 of 2.3 nMForm:SolidIC50&amp: Target:IC50: 2.3 nM (Cholesteryl ester

CLK1-IN-1 is a potent and selective of Cdc2-like kinase 1 ( CLK1 ) inhibitor, with an IC 50 of 2 nM.In VitroCLK1 is the most potently inhibited kinase (IC 50 : 2 nM). In addition to CLK1, only two kinases have an IC 50 value less than 100 nM, namely